Literature DB >> 5430281

Pseudomembraneous colitis as a sequel to oral lincomycin therapy.

E J Benner, W H Tellman.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 5430281

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


× No keyword cloud information.
  17 in total

Review 1.  Clindamycin--efficacy and toxicity.

Authors:  R I Frankel
Journal:  West J Med       Date:  1975-06

2.  Familial pseudomembranous colitis and its relation to lincomycin therapy.

Authors:  M J Harrod; M S Brown; A G Weinberg; W N Harkness; J L Goldstein
Journal:  Am J Dig Dis       Date:  1975-09

3.  Editorial: Antibiotic diarrhoea.

Authors: 
Journal:  Br Med J       Date:  1975-11-01

4.  Ampicillin-associated diarrhea--A prospective study.

Authors:  F J Tedesco
Journal:  Am J Dig Dis       Date:  1975-04

5.  Pseudomembranous colitis associated with antibiotic therapy - an emerging entity.

Authors:  S Fenton; D Stephenson; C Weder
Journal:  Can Med Assoc J       Date:  1974-11-16       Impact factor: 8.262

6.  Letter: Lincomycin and clindamycin colitis.

Authors: 
Journal:  Br Med J       Date:  1974-12-07

7.  Clindamycin colitis--an emerging problem.

Authors:  W D Carey; M Brotman
Journal:  West J Med       Date:  1974-12

8.  Identification of adverse reactions to new drugs. II (continued): How were 18 important adverse reactions discovered and with what delays?

Authors:  G R Venning
Journal:  Br Med J (Clin Res Ed)       Date:  1983-01-29

9.  Purified Clostridium difficile cytotoxin stimulates guanylate cyclase activity and inhibits adenylate cyclase activity.

Authors:  D L Vesely; K D Straub; C M Nolan; R D Rolfe; S M Finegold; T P Monson
Journal:  Infect Immun       Date:  1981-07       Impact factor: 3.441

10.  Survey of the extrachromosomal gene pool of Clostridium difficile.

Authors:  L L Muldrow; E R Archibold; O L Nunez-Montiel; R J Sheehy
Journal:  J Clin Microbiol       Date:  1982-10       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.